c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation

Jia, GQ; Li, FJ; Tong, RY; Liu, Y; Zuo, MN; Ma, LB; Ji, X

Ma, LB; Ji, X (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou, Inner Mongolia, Peoples R China.

MEDICAL ONCOLOGY, 2020; 37 (12):

Abstract

Radiofrequency ablation (RFA) is popularly used in the treatment of hepatocellular carcinoma (HCC). However, the accelerated malignant progression of ......

Full Text Link